Reversal of the multidrug resistance by drug combination using multifunctional liposomes
One of the major obstacles to the success of cancer chemotherapy is the multi-drug resistance (MDR) that results due mainly to the over-expression of drug efflux transporter pumps such as P-glycoprotein (P-gp). Highly efficacious third generation P-gp inhibitors, like tariquidar, have shown promisin...
Published: |
|
---|---|
Online Access: | http://hdl.handle.net/2047/d20003274 |
Similar Items
-
Nanoemulsions Within Liposomes for Cytosolic Drug Delivery to Multidrug-Resistant Cancer Cells
by: Williams, Jacob Brian
Published: (2016) -
Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment
by: Duopeng An, et al.
Published: (2021-02-01) -
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
by: Meng Lei, et al.
Published: (2019-01-01) -
Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
by: Hua H, et al.
Published: (2017-10-01) -
Reversal of multidrug resistance in human lung cancer cells by delivery of 3-octadecylcarbamoylacrylic acid–cisplatin-based liposomes
by: Song J, et al.
Published: (2017-02-01)